Back to Trades
Tan Lee Su-Leng
CEODirectorCIK 0002141883
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Tan Lee Su-Leng, CEO, Director, accounts for 1 disclosed filing worth $0, all concentrated in BioNexus Gene Lab Corp (BGLC), active 2026. Data is sourced from official SEC Form 3, 4, and 5 filings.